3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Breast Neoplasms
2
Urologic Diseases
1
Pancreatic Neoplasms
1
Nephritis
1
Neoplasms
1
Melanoma
1
Mastocytosis
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Kidney Diseases
1
Immune System Diseases
1
Hypoxia
1
Glomerulonephritis, IGA
1
Glomerulonephritis
1
Carcinoma, Non-Small-Cell Lung
1
COVID-19
1
Autoimmune Diseases
1
Interventions
midostaurin
1
masitinib
1
Phlebotomy
1
Hydroxychloroquine
1
Cladribine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Mastocytosis
×
Hydroxychloroquine
×
Clear all
NCT05084872
2021-10-20
HCQMa
University Hospital, Toulouse
Phase 2/3
Unknown
30 enrolled